MyFinsight
Home
Blog
About
Back
Income Statement
Damora Therapeutics, Inc. (DMRA)
Damora Therapeutics, Inc. (DMRA)
source: myfinsight.com
Total comprehensive
loss
-$31,196K
Net loss
-$31,174K
Other comprehensive
(loss) income, net of...
-$22K
Common Stock
-$24,055K
Series BNon Voting
Convertible Preferred Stock
-$6,441K
Series CNon Voting
Convertible Preferred Stock
-$678K
Currency translation
(loss) gain
-$22K
Back